S&P 500   2,997.87 (+1.07%)
DOW   27,036.90 (+0.93%)
QQQ   193.36 (+1.18%)
AAPL   235.89 (+0.01%)
MSFT   141.44 (+1.35%)
GOOGL   1,240.65 (+1.88%)
CGC   19.99 (+5.99%)
NVDA   198.56 (+6.45%)
MU   46.30 (+3.21%)
TSLA   259.27 (+0.90%)
AMD   30.65 (+0.39%)
T   37.87 (+1.07%)
DIS   129.80 (+0.08%)
S&P 500   2,997.87 (+1.07%)
DOW   27,036.90 (+0.93%)
QQQ   193.36 (+1.18%)
AAPL   235.89 (+0.01%)
MSFT   141.44 (+1.35%)
GOOGL   1,240.65 (+1.88%)
CGC   19.99 (+5.99%)
NVDA   198.56 (+6.45%)
MU   46.30 (+3.21%)
TSLA   259.27 (+0.90%)
AMD   30.65 (+0.39%)
T   37.87 (+1.07%)
DIS   129.80 (+0.08%)
Log in

Innospec Stock Price, News & Analysis (NASDAQ:IOSP)

$91.30
+2.21 (+2.48 %)
(As of 10/15/2019 12:43 PM ET)
Today's Range
$89.40
Now: $91.30
$91.30
50-Day Range
$81.92
MA: $88.33
$95.36
52-Week Range
$53.07
Now: $91.30
$97.18
Volume1,643 shs
Average Volume108,216 shs
Market Capitalization$2.24 billion
P/E Ratio18.84
Dividend Yield1.13%
Beta1.29
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNASDAQ:IOSP
CUSIP45768S10
Phone303-792-5554

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.48 billion
Cash Flow$7.14 per share
Book Value$33.80 per share

Profitability

Net Income$85 million

Miscellaneous

Employees2,000
Market Cap$2.24 billion
Next Earnings Date11/5/2019 (Confirmed)
OptionableOptionable

Receive IOSP News and Ratings via Email

Sign-up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.


Innospec (NASDAQ:IOSP) Frequently Asked Questions

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec declared a Semi-Annual dividend on Tuesday, May 7th. Stockholders of record on Tuesday, May 21st will be given a dividend of $0.50 per share on Thursday, May 30th. This represents a dividend yield of 1.18%. The ex-dividend date is Monday, May 20th. View Innospec's Dividend History.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) announced its earnings results on Tuesday, August, 6th. The specialty chemicals company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.02. The specialty chemicals company earned $362.40 million during the quarter, compared to analyst estimates of $371.20 million. Innospec had a return on equity of 15.11% and a net margin of 6.10%. The firm's quarterly revenue was up 1.2% on a year-over-year basis. During the same period last year, the firm earned $0.80 EPS. View Innospec's Earnings History.

When is Innospec's next earnings date?

Innospec is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Innospec.

How can I listen to Innospec's earnings call?

Innospec will be holding an earnings conference call on Tuesday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for IOSP?

2 brokerages have issued 1 year target prices for Innospec's shares. Their forecasts range from $83.00 to $95.00. On average, they expect Innospec's share price to reach $89.00 in the next year. This suggests that the stock has a possible downside of 2.5%. View Analyst Price Targets for Innospec.

What is the consensus analysts' recommendation for Innospec?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innospec.

Has Innospec been receiving favorable news coverage?

Press coverage about IOSP stock has trended somewhat negative on Tuesday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Innospec earned a coverage optimism score of -1.1 on InfoTrie's scale. They also gave media headlines about the specialty chemicals company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Innospec.

Are investors shorting Innospec?

Innospec saw a decrease in short interest in September. As of September 30th, there was short interest totalling 342,200 shares, a decrease of 10.1% from the August 30th total of 380,700 shares. Based on an average daily volume of 115,700 shares, the short-interest ratio is currently 3.0 days. Currently, 1.4% of the shares of the company are short sold. View Innospec's Current Options Chain.

Who are some of Innospec's key competitors?

What other stocks do shareholders of Innospec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include Intellia Therapeutics (NTLA), NVIDIA (NVDA), Applied Materials (AMAT), B&G Foods (BGS), Colgate-Palmolive (CL), Emerson Electric (EMR), UnitedHealth Group (UNH), XPO Logistics (XPO), Zayo Group (ZAYO) and Adobe (ADBE).

Who are Innospec's key executives?

Innospec's management team includes the folowing people:
  • Mr. Patrick S. Williams, Pres, CEO & Director (Age 54)
  • Mr. Ian P. Cleminson, Exec. VP & CFO (Age 53)
  • Dr. Philip J. Boon, COO & Exec. VP (Age 60)
  • Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 70)
  • Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 60)

Who are Innospec's major shareholders?

Innospec's stock is owned by a number of of institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.08%) and Diversified Trust Co (0.01%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.

Which institutional investors are selling Innospec stock?

IOSP stock was sold by a variety of institutional investors in the last quarter, including Diversified Trust Co. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, Ian Cleminson, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.

Which institutional investors are buying Innospec stock?

IOSP stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. View Insider Buying and Selling for Innospec.

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $91.30.

How big of a company is Innospec?

Innospec has a market capitalization of $2.24 billion and generates $1.48 billion in revenue each year. The specialty chemicals company earns $85 million in net income (profit) each year or $4.83 on an earnings per share basis. Innospec employs 2,000 workers across the globe.View Additional Information About Innospec.

What is Innospec's official website?

The official website for Innospec is http://www.innospecinc.com/.

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]


MarketBeat Community Rating for Innospec (NASDAQ IOSP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  232 (Vote Outperform)
Underperform Votes:  227 (Vote Underperform)
Total Votes:  459
MarketBeat's community ratings are surveys of what our community members think about Innospec and other stocks. Vote "Outperform" if you believe IOSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel